As of Aug 21
| +0.14 / +3.04%|
The 2 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +68.78% increase from the last price of 4.74.
The current consensus among 2 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.